Galapagos N.V. | Mutual Funds
Mutual Funds that own Galapagos N.V.
American Funds EuroPacific Growth Fund
1,350,000
2.63%
0
0.1%
06/30/2018
American Funds Small Cap World Fund
803,989
1.57%
0
0.22%
06/30/2018
Government Pension Fund - Global (The)
707,441
1.38%
-181,748
0.01%
12/31/2017
Vanguard Total International Stock Index Fund
630,989
1.23%
17,804
0.02%
07/31/2018
Universal Invest Global Flexible
524,000
1.02%
27,500
0.48%
06/30/2018
Federated Kaufmann Fund
510,000
0.99%
0
0.76%
06/29/2018
Oppenheimer International Small Company Fund
491,865
0.96%
0
0.48%
02/28/2018
Vanguard Health Care Fund
364,320
0.71%
81,441
0.07%
06/30/2018
Worldwide Healthcare Trust Plc
285,108
0.56%
186,825
1.4%
09/30/2017
DFA Continental Small Company Series
282,394
0.55%
34,608
0.46%
01/31/2018
| Address |
Industriepark Mechelen Noord
Mechelen BU 2800
Belgium
|
|
Employees
|
- |
| Website |
http://www.glpg.com |
| Updated |
07/08/2019 |
| Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium. |
